“Tau Protein Targeting Via Radioiodinated Azure A For Brain Theranostics: Radiolabeling, Molecular Docking, in vitro And in vivo Biological Evaluation”
Molecularclip 1 remains monomeric in water and engages in host–guest recognition processes with suitable guests. We report the Ka values for 32 1⋅guest complexes measured by 1H NMR, UV/Vis, and fluorescence titrations. The cavity of 1 is shaped by aromatic surfaces of negative electrostatic potential and therefore displays high affinity and selectivity for planar and cationic aromatic guests that
分子夹1在水中仍然是单体,并与合适的客人一起参与宿主-客体识别过程。我们报告了通过1 H NMR,UV / Vis和荧光滴定法测得的32个1⋅客体配合物的K a值。1的腔体由负电势的芳族表面形成,因此对平面和阳离子芳族客体显示出高亲和力和选择性,这使其与CB [ n ]受体相区别,后者比脂族客体更喜欢脂肪族。静电作用在识别过程中起着主要作用,在此过程中,铵离子和C = O的1个基团之间可能发生离子-偶极相互作用。情况下,SO之间3 -基团的1和在来宾悬垂阳离子基团,和空腔内1由阳离子-π相互作用。宿主1对具有大的平面芳族表面(例如萘二酰亚胺NDI +和per二酰亚胺PDI +)和衍生自a啶的阳离子染料(例如亚甲基蓝和天蓝色A)表现出较高的亲和力。通过比较类似的中性和阳离子客体(例如,亚甲基紫与亚甲基蓝;喹啉与N-甲基喹啉鎓; a啶与N-甲基ac啶;中性红与中性红H +)可以确定阳离子-π相
[EN] METHODS AND COMPOSITIONS USING REPAIR CELLS AND CATIONIC DYES<br/>[FR] MÉTHODES ET COMPOSITIONS UTILISANT DES CELLULES RÉPARATRICES ET DES COLORANTS CATIONIQUES
申请人:MEDIVATION TECHNOLOGIES INC
公开号:WO2017019832A1
公开(公告)日:2017-02-02
This disclosure describes compositions and methods for delivering and localizing repair cells to therapeutic targets.
这份披露描述了将修复细胞传递和定位到治疗靶点的组合物和方法。
[EN] COMPOSITIONS CONTAINING REPAIR CELLS AND CATIONIC DYES<br/>[FR] COMPOSITIONS CONTENANT DES CELLULES DE RÉPARATION ET DES COLORANTS CATIONIQUES
申请人:MEDIVATION TECHNOLOGIES INC
公开号:WO2017019833A1
公开(公告)日:2017-02-02
This disclosure describes compositions and methods for delivering and localizing repair cells, such as mesenchymal stem cells (MSCs) to the sites of tissue injuries, including cartilage injuries. This disclosure also describes methods for chondrogenic differentiation of MSCs in pellet compositions.
Reagents and methods for direct labeling of nucleotides
申请人:Naleway John J.
公开号:US20130150254A1
公开(公告)日:2013-06-13
The present invention provides systems and methods for production of activatable diazo-derivatives for use in labeling nucleotides. Labeling nucleotides is accomplished by contacting a stable hydrazide derivative of a detectable moiety with an activating polymer reagent which is used to directly label the nucleotide sample. Labeling occurs on the phosphate backbone of the nucleotide which does not perturb hybridization of the labeled nucleotide with its anti-sense strand. Since the method involves direct labeling, all types of nucleotides can be labeled without prior amplification or alteration.
This disclosure describes compositions and methods for delivering and localizing therapeutic agents to therapeutic targets. This disclosure also provides multivalent forms of cationic dyes ("cationic dye multimers") and methods by which these compounds can be used to treat joint injuries.